Dose-finding Study to Evaluate Immunogenicity of Three Different Dose

See also
Status	Clinical Trial	Phase
Completed	`NCT05976100` - Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years	Phase 1
Completed	`NCT01540929` - Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel
Completed	`NCT00258947` - Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults	Phase 2
Completed	`NCT00189969` - Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects	Phase 1
Terminated	`NCT00053508` - Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination	Phase 2
Completed	`NCT01317238` - Safety and Efficacy of CJ Smallpox Vaccine in Previously Vaccinated Healthy Volunteers	Phase 3
Completed	`NCT01056770` - Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers	Phase 3
Withdrawn	`NCT00389103` - Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)	Phase 1
Terminated	`NCT00282581` - Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive	Phase 1
Completed	`NCT00998543` - A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain)	Phase 2
Completed	`NCT00133575` - ACAM 3000 MVA at Harvard Medical School	Phase 1/Phase 2
Active, not recruiting	`NCT00103584` - Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers	Phase 1/Phase 2
Completed	`NCT00050505` - Expanded Dryvax Dilution Study in Previously Vaccinated Adults	Phase 2
Completed	`NCT05846243` - Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years	Phase 2/Phase 3
Completed	`NCT05935917` - Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults	Phase 1
Completed	`NCT00082446` - Combination Study With MVA BN and Dryvax	Phase 1
Completed	`NCT00038987` - Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT	Phase 1/Phase 2
Completed	`NCT05762523` - Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years	Phase 1
Completed	`NCT04971109` - Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Day	Phase 3
Completed	`NCT00646152` - Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study	Phase 1

NCT number	NCT00189956
Study type	Interventional
Source	Bavarian Nordic
Contact
Status	Completed
Phase	Phase 2
Start date	April 2003
Completion date	December 2005

Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms